Salud financiera de hoja de balance de SMS Pharmaceuticals
Salud financiera controles de criterios 4/6
SMS Pharmaceuticals tiene un patrimonio de accionistas total de ₹4.8B y una deuda total de ₹2.8B, lo que sitúa su ratio deuda-patrimonio en 57.8%. Sus activos y pasivos totales son ₹9.8B y ₹5.0B respectivamente. El BAIT de SMS Pharmaceuticals es de ₹745.8M, por lo que su ratio de cobertura de intereses es de 3.4. Tiene efectivo e inversiones a corto plazo que ascienden a ₹329.2M.
Información clave
57.8%
Ratio deuda-patrimonio
₹2.77b
Deuda
| Ratio de cobertura de intereses | 3.4x |
| Efectivo | ₹329.25m |
| Patrimonio | ₹4.79b |
| Total pasivo | ₹4.98b |
| Activos totales | ₹9.77b |
Actualizaciones recientes sobre salud financiera
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07
We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09
Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Matching Investor Opinion
Jul 07Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹5.0B) de SMSPHARMA superan a sus pasivos a corto plazo (₹3.4B).
Pasivo a largo plazo: Los activos a corto plazo de SMSPHARMA (₹5.0B) superan a sus pasivos a largo plazo (₹1.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de SMSPHARMA (50.9%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de SMSPHARMA ha crecido de 44.8% a 57.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de SMSPHARMA está bien cubierta por el flujo de caja operativo (27.2%).
Cobertura de intereses: Los pagos de intereses de la deuda de SMSPHARMA están bien cubiertos por el BAIT (3.4x cobertura).